Literature DB >> 24445155

Exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strains and their polymers elicit different responses on immune cells from blood and gut associated lymphoid tissue.

Claudio Hidalgo-Cantabrana1, Milica Nikolic2, Patricia López3, Ana Suárez3, Marija Miljkovic2, Milan Kojic2, Abelardo Margolles4, Natasa Golic2, Patricia Ruas-Madiedo5.   

Abstract

The effect of exopolysaccharide (EPS) producing bifidobacteria, and the EPS derived thereof, on the modulation of immune response was evaluated. Cells isolated from gut associated lymphoid tissue (GALT) and from peripheral blood mononuclear cells (PBMC) of naïve rats were used. The proliferation and cytokine production of these immune cells in the presence of the three isogenic Bifidobacterium animalis subsp. lactis strains (A1, A1dOx and A1dOxR), as well as their purified polymers, were in vitro analysed. The cytokine pattern produced by immune cells isolated from GALT showed that most levels remained stable in the presence of the three strains or their corresponding polymers. However, in PBMC the UV-inactivated bacteria induced higher levels of the ratios IFNγ/IL-17, TNFα/IL-10 and TNFα/TGFβ, and no variation in the ratio IFNγ/IL-4. Thus, B. animalis subsp. lactis strains were able to activate blood monocytes as well as T lymphocytes towards a mild inflammatory Th1 response. Furthermore, only the EPS-A1dOxR was able to stimulate a response in a similar way than its EPS-producing bacterium. Our work supports the notion that some bifidobacterial EPS could play a role in mediating the dialog of these microorganisms with the immune system. In addition, this study emphasizes the effect that the origin of the immune cells has in results obtained; this could explain the great amount of contradiction found in literature about the immunomodulation capability of EPS from probiotic bacteria.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bifidobacteria; Cytokine; Exopolysaccharide; GALT; Immune response; PBMC

Mesh:

Substances:

Year:  2014        PMID: 24445155     DOI: 10.1016/j.anaerobe.2014.01.003

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  17 in total

1.  A single mutation in the gene responsible for the mucoid phenotype of Bifidobacterium animalis subsp. lactis confers surface and functional characteristics.

Authors:  Claudio Hidalgo-Cantabrana; Borja Sánchez; Pablo Álvarez-Martín; Patricia López; Noelia Martínez-Álvarez; Michele Delley; Marc Martí; Encarna Varela; Ana Suárez; María Antolín; Francisco Guarner; Bernard Berger; Patricia Ruas-Madiedo; Abelardo Margolles
Journal:  Appl Environ Microbiol       Date:  2015-09-11       Impact factor: 4.792

2.  Distinct immunomodulation of bone marrow-derived dendritic cell responses to Lactobacillus plantarum WCFS1 by two different polysaccharides isolated from Lactobacillus rhamnosus LOCK 0900.

Authors:  Sabina Górska; Martin Schwarzer; Wojciech Jachymek; Dagmar Srutkova; Ewa Brzozowska; Hana Kozakova; Andrzej Gamian
Journal:  Appl Environ Microbiol       Date:  2014-08-08       Impact factor: 4.792

3.  Mycoplasma agalactiae Secretion of β-(1→6)-Glucan, a Rare Polysaccharide in Prokaryotes, Is Governed by High-Frequency Phase Variation.

Authors:  P Gaurivaud; E Baranowski; C Pau-Roblot; E Sagné; C Citti; F Tardy
Journal:  Appl Environ Microbiol       Date:  2016-05-16       Impact factor: 4.792

4.  Soluble bioactive microbial mediators regulate proteasomal degradation and autophagy to protect against inflammation-induced stress.

Authors:  Yuhei Inaba; Nobuhiro Ueno; Masatsugu Numata; Xiaorong Zhu; Jeannette S Messer; David L Boone; Mikihiro Fujiya; Yutaka Kohgo; Mark W Musch; Eugene B Chang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-11       Impact factor: 4.052

5.  Evaluation of probiotic potential of yeasts isolated from traditional cheeses manufactured in Serbia and Croatia.

Authors:  Milica Živković; Neža Čadež; Ksenija Uroić; Marija Miljković; Maja Tolinački; Petra Doušova; Blaženka Kos; Jagoda Šušković; Peter Raspor; Ljubiša Topisirović; Nataša Golić
Journal:  J Intercult Ethnopharmacol       Date:  2015-01-03

Review 6.  Bifidobacteria-host interactions--an update on colonisation factors.

Authors:  Verena Grimm; Christina Westermann; Christian U Riedel
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

7.  EPS-SJ Exopolisaccharide Produced by the Strain Lactobacillus paracasei subsp. paracasei BGSJ2-8 Is Involved in Adhesion to Epithelial Intestinal Cells and Decrease on E. coli Association to Caco-2 Cells.

Authors:  Milica Živković; Marija S Miljković; Patricia Ruas-Madiedo; Milica B Markelić; Katarina Veljović; Maja Tolinački; Svetlana Soković; Aleksandra Korać; Nataša Golić
Journal:  Front Microbiol       Date:  2016-03-09       Impact factor: 5.640

8.  In vitro and in vivo antagonistic activity of new probiotic culture against Clostridium difficile and Clostridium perfringens.

Authors:  Nataša Golić; Katarina Veljović; Nikola Popović; Jelena Djokić; Ivana Strahinić; Igor Mrvaljević; Amarela Terzić-Vidojević
Journal:  BMC Microbiol       Date:  2017-05-06       Impact factor: 3.605

Review 9.  Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.

Authors:  Rodrigo D De Oliveira Carvalho; Fillipe L R do Carmo; Alberto de Oliveira Junior; Philippe Langella; Jean-Marc Chatel; Luis G Bermúdez-Humarán; Vasco Azevedo; Marcela S de Azevedo
Journal:  Front Microbiol       Date:  2017-05-09       Impact factor: 5.640

10.  Effect of a Ropy Exopolysaccharide-Producing Bifidobacterium animalis subsp. lactis Strain Orally Administered on DSS-Induced Colitis Mice Model.

Authors:  Claudio Hidalgo-Cantabrana; Francesca Algieri; Alba Rodriguez-Nogales; Teresa Vezza; Pablo Martínez-Camblor; Abelardo Margolles; Patricia Ruas-Madiedo; Julio Gálvez
Journal:  Front Microbiol       Date:  2016-06-09       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.